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      The study was designated to complete a chemical and ecological evaluation of a genuine Chinese medicine 
Atractylodes macrocephala Koidz (A. macrocephala) and to explore the existence of correlation between chemical 
ingredients of different A. macrocephala populations and ecological factors. Different samples of A. macrocephala collected 
from six Chinese habitats were analyzed using chemical and ecological methods. The results showed the bioactive 
ingredients of A. macrocephala to be closely related to ecological factors. The study can serve the purposes of preservation 
and development of genuine Chinese medicines. 
 






           Atractylodes macrocephala Koidz (A. macrocephala), a Chinese medicinal herb, has been extensively used 
to treat digestive diseases in China and most other Asian countries (PPRC, 2005; Lee et al, 2007). Dry rhizomes of A. 
macrocephala are rich in sesquiterpenes and acetylenic compounds (Endo et al, 1979; Chen 1987; Huang et al, 1992; Lin et 
al, 1997). Typical polysaccharides atractan A, B, and C, present in A. macrocephala, have been reported to exhibit 
hypoglycaemic activities (Wang et al, 2000; Jia et al, 2003). Although atractylenolide I, atractylenolide II and atractylenolide 
III are all bioactive substances present in Atractylodes macrocephalae, the majority of research studies carried out in the 
recent years have focused on atractylenolide II and atractylenolide III (Kang et al., 2011b). Atractylenolide II is a marker 
substance present in Atractylodes macrocephalae which exhibits well-documented gastrointestinal inhibitory effects and 
anticancer activity (Zhang et al., 1999; Liu et al., 2005). Atractylenolide II is one of the main constituents present in the 
effective volatile oil fraction (Li et al., 2001), potentially effective in treating senile dementia (Ge et al., 2007). 
Atractylenolide III was shown to inhibit the secretion and expression of IL-6 in phorbol 12-myristate 13-acetate- and calcium 
ionophore A23187-stimulated human mast cells (HMC)-1 (Kang et al., 2011b). In addition, atractylenolide III inhibited 
histamine release in stimulated HMC-1 cells, in which it may control immunological reactions by virtue of regulating cellular 
functions of IL-6 in mast cells (Kang et al., 2011b). Atractylenolide III can also induce apoptosis of lung carcinoma cells by 
inhibiting cell growth and increasing lactate dehydrogenase release (Dong et al., 2008). Moreover, atractylenolide III is a 
possible candidate for the treatment of human lung carcinoma (Kang et al., 2011a).  
The term “genuine herb” refers to the traditional Chinese herb featured by region-specific characteristics, an outstanding 
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clinical efficacy, fixed processing method, and high quality. Ecological factors may play an important role in genuine herb 
formation, particularly when it comes to secondary metabolites’ accumulation (Huang et al, 2007).  
The study was designated to complete a chemical and ecological evaluation of A. macrocephala, a genuine Chinese medicine, 




Materials and Methods 
Plant materials 
 
       Samples of A. macrocephala (20090829, 20090912, 20090811, 20091005, 20090803, 20091017) were collected 
from six different habitats in China: Zhejiang Province, Anhui Province, Jiangxi Province, Chongqing City, Hunan Province 
and Hebei Province.  
 
Chemicals and reagents 
 
       Analytical grade-methanol was purchased from Sigma Aldrich, UK. HPLC-grade water, acetonitrile and 
tetrahydrofuran (THF) were purchased from Fisher Scientific UK. The liquid chromatographic system used was a Waters 
HPLC System (Waters, Milford, MA, USA) equipped with a 2996 photodiode-array (PDA) UV detector, Waters 626 Pump, 
and Waters 600 Controller (LCD), Waters 717 plus Auto-sampler. Chromatographic separation of the three compounds was 
achieved using a reversed-phase HPLC column (Agilent ZORBAX Rx-C18 2.1 x 150 mm, 5 μm). 
 
Contents’ Determination, Extraction and isolation  
 
       Ten (10) g of A. macrocephala was refluxed for 60 minutes with 100 ml of water remained in the flask by means 
of Soxhlet-extraction. After filtration, the extraction procedure was repeated using 80 mL of water. The filtrate was 
concentrated in vacuo and freeze-dried. Each freeze-dried sample was weighed with the maximal precision, dissolved in 
water, and filtered through a membrane filter (0.45 μm). The samples were injected into HPLC. The extraction flowchart is 
presented in Figure 1.  
 
Added 8× water reflux for 1h, filtrate 
Freeze-dried powder 
10g of A. macrocephala 
Filtrate I 
Added 10× water reflux for 1h, filtrate 
Filtrate II 
Analysis using HPLC 
Condensed in vacuo 
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Figure 1 Flowchart descriptive of the conventional extraction of A. macrocephala 
 
HPLC setting  
 
       Gradient elution employed in HPLC analysis consisted of two solvent compositions: 0.5% tetrahydrofuran (THF) 
dissolved in water (solvent A) and acetonitrile (solvent B). Gradient elution was carried out according to the following 
program: 0-5 min, 0-40%; 5-15 min, 40-55%; 15-60 min, 55-90%. The flow rate was 0.2 μl/min. The sample injection 
volume was 3 μl. Both the column and the auto-sampler were set at the ambient temperature. The eluent was monitored by an 
UV detector operating at the wavelengths of 220 nm and 230 nm so as to detect atractylenolide II and III. 
 
Preparation of standard solutions and calibration curves  
 
      Standard stock solutions (730.0 μg/ml of atractylenolide II and 470.0 μg/ml of atractylenolide III) were prepared 
separately in 50%-methanol. Standard working solutions of atractylenolide II and atractylenolide III were prepared by virtue 
of diluting their original stock solutions with 50%-methanol so as to reach the final concentrations of 73.0 μg/ml, and 47.0 
μg/ml, respectively. Mixed standard solution was prepared using 200 ml of atractylenolide II and atractylenolide III mixed 
together so as to reach the final concentrations of atractylenolide II and atractylenolide III of 15.0 μg/ml and 16.0 μg/ml, 
respectively. Working standard solutions and quality control sample solutions were prepared in high, medium and low 
concentrations by diluting the standard stock solutions with 50%-methanol in order to retrieve atractylenolide II and 
atractylenolide III. These solutions were all kept in brown glass bottles and stored at −20 ˚C.  
Calibration curves were obtained by plotting the peak-area ratio of each analyte standard versus analyte concentration. The 
studied concentration ranges were 0.73–73.0 μg/ml for atractylenolide II and 0.48–48.0μg/ml for atractylenolide III. 
 
Validation of the method 
 
       Validation of the HPLC method was performed by determining the intra-day and inter-day accuracy and precision. 
Quality control samples were analyzed in a set of five on a single assay day so as to determine intra-day precision and 
accuracy. They were also analyzed in duplicate on three separate days so as to determine inter-day precision and accuracy. 
Quality control samples were used in low, medium and high concentrations (atractylenolide II: 18.3, 36.5, 73 μg/ml; 




        Data were analysed by an independent university-based statistician by virtue of hierarchical cluster analysis 
using the Statistical Package for Social Sciences (SPSS 13.0 for Windows). Multiple stepwise linear regression analysis was 
performed to demonstrate the correlation between the contents of atractylenolide II and atractylenolide III present in A. 
macrocephala and ecological factors. The content of atractylenolide II and atractylenolide III acted as a dependent,variable, 
while ecological factors acted as independent variables. 
 
 
Results and Discussion 
Calibration curve 
 
        The regression equation was calculated as Y = AX+B, where Y represents the peak area and X represents the 
content of the constituent. The regression equations of atractylenolide II and atractylenolide III were 
doi: 10.4314/ajtcam.v8i4.10
Zhou et al.,  Afr J Tradit Complement Altern Med. (2011) 8(4):405‐411 
 
408
Y=1464851.82X-81346.00 (r2=0.9997), and Y=498989.66X+13987.51 (r2=0.9990), respectively.  
Content determination  
 
         HPLC sample chromatogram obtained at 230 nm and 3-dimensional HPLC chromatogram are presented in 
Figure 2. HPLC fingerprints of the samples harvested on six different habitats and analysed at 220 nm are presented in Figure 
3. The contents of atractylenolide II and atractylenolide III present in A. macrocephala originating from different habitats are 





Figure 2 HPLC chromatogram of A. macrocephala.  
Note: 
(A) chromatogram of A. macrocephala (wavelength=230 nm) 
(B) 3-dimensional chromatogram of A. macrocephala 
Chromatographic setting:  
Solvent A: 0.5% tetrahydrofuran (THF) dissolved in water; solvent B: acetonitrile.  










Figure 3:   HPLC fingerprints of A. macrocephala from different habitats (220 nm). 
Note: From bottom to top, the samples were harvested in Zhejiang Province, Anhui Province, Jiangxi Province, Chongqing 
City, Hunan Province and Hebei Province. 
3= atractylenolide III, 2= atractylenolide II 
 
Table 1: Contents of atractylenolide II and atractylenolide III present in A. macrocephala originating from different habitats 
(mean ± SD) 
Habitats Atractylenolide II  (μg/ml) Atractylenolide III (μg/ml) 
Zhejiang Province 13.66 31.89 
Anhui Province 10.65 23.53 
Jiangxi Province    11.90 23.99 
Chongqing City   12.08 26.48 
Hunan Province   9.32 22.61 
Hebei Province    8.40 19.77 
 
 
Based on the content of atractylenolide II and atractylenolide III present in A. macrocephala samples, the 
six habitats were finally classified as group 1 (Zhejiang Province), group 2 (Anhui Province, Jiangxi 
Province, Chongqing City) and group 3 (Hunan Province, Hebei Province). The sample from Zhejiang 
Province was proven to be the best source of A. macrocephala. 
 
Ecological Evaluation  
 
        A. macrocephala samples were collected from six different Chinese habitats. Ecological factors descriptive of 
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contents present in A. macrocephala samples, the six habitats were finally classified as group 1 (Zhejiang Province), group 2 
(Anhui Province, Jiangxi Province, Chongqing City) and group 3 (Hunan Province, Hebei Province).   
 
Table 2: Ecological factors descriptive of six A. macrocephala habitats 
Habitats Longitude E 








Zhejiang Province 120.59 20.99 16-22 800-1500 Red 
Anhui Province 117.48 30.56 14-20 800-1500 Red 
Jiangxi Province    115.58 29.43 16-21 800-1500 Red 
Chongqing City   106:33 29:33 16-21 2000-2500 Yellow 
Hunan Province   112.59 28.12 15-20 800-1500 Red 




     In the present study, ecological factors including longitude, latitude, annual precipitation, annual average 
temperature and soil were considered. Amongst these, longitude, latitude and annual average temperature positively 
correlated with A. macrocephala atractylenolide II and atractylenolide III contents. The result of the multiple linear stepwise 
regression analysis showed the longitude, latitude and annual average temperature to be capable of influencing the 
accumulation of atractylenolide II and atractylenolide III.  The study showed A. macrocephala samples collected in 
Zhejiang Province to have higher contents of atractylenolide II and atractylenolide III as compared to those harvested on 
other habitats; the credit should be given to ecological factors of Zhejiang Province which favour the accumulation of 
chemical ingredients in A. macrocephala. A close correlation between chemical ingredients present in different A. 
macrocephala populations and ecological factors was uncovered.  
          Various ecological settings, as well as harvesting and processing methods, often lead to differences in quality 
of traditional Chinese medicines. The term “genuine herb” refers to the traditional Chinese herb featured by region-specific 
characteristics, an outstanding clinical efficacy, fixed processing method and high quality. Dried rhizome of A. macrocephala 
is a common Chinese medicinal herb widely used in most of the Chinese formula (Lin et al, 2008). Understanding of the 
scientific basis of traditional genuine medical knowledge is an essential requirement for maintaining and preserving these 
remedial herbs (Said, 2002). The present study was designated to complete a chemical and ecological evaluation of A. 
macrocephala, a genuine Chinese medicine, and to explore the existence of correlation between chemical ingredients present 
in different A. macrocephala populations and ecological factors. The present research evaluated the quality of six different 
original samples of A. macrocephala using chemical and ecological methods. This study primarily revealed the scientific 
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